Sherman Michael A.

CIK 00015094636 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001509463

Recent Transactions

50 trades

Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2025-06-12+27,000→ 27,000 total
Disposition to Issuer
CHIMERIX INC
Common Stock
2025-04-21$8.55/sh−87,000→ 0 total
Disposition to Issuer
CHIMERIX INC
Common Stock
2025-04-21$8.55/sh−102,995→ 0 total
Disposition to Issuer
CHIMERIX INC
Common Stock
2025-04-21$8.55/sh−233,413→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−557,050→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−60,000→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−632,500→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−1,150,000→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−700,000→ 0 total
Disposition to Issuer
CHIMERIX INC
Employee Stock Option (Right to Buy)
2025-04-21−875,000→ 0 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2024-06-20+60,000→ 60,000 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2024-05-24+17,500→ 17,500 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2023-06-21+13,200→ 13,200 total
Purchase
CHIMERIX INC
Common Stock
2023-05-12$1.13/sh+11,985→ 11,985 total
Purchase
CHIMERIX INC
Common Stock
2023-05-12$1.12/sh+75,015→ 87,000 total
Award
CHIMERIX INC
Common Stock
2023-01-17+92,950→ 222,995 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2023-01-17+557,050→ 557,050 total
Exercise/Conversion
CHIMERIX INC
Employee Stock Option (Right to Buy)
2022-07-25−100,000→ 1,150,000 total
Exercise/Conversion
CHIMERIX INC
Common Stock
2022-07-25$2.09/sh+100,000→ 125,364 total
Exercise/Conversion
CHIMERIX INC
Common Stock
2022-07-25$2.09/sh+100,000→ 125,364 total
Exercise/Conversion
CHIMERIX INC
Employee Stock Option (Right to Buy)
2022-07-25−100,000→ 1,150,000 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2022-06-01+11,600→ 11,600 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2022-01-18+875,000→ 875,000 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2021-05-27+23,200→ 23,200 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2021-01-22+700,000→ 700,000 total
Disposition to Issuer
BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
2020-12-02$32.87/sh−6,000→ 0 total
Disposition to Issuer
BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
2020-12-02−2,018→ 0 total
Award
BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
2020-05-01+6,000→ 6,000 total
Award
BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
2020-04-13+2,018→ 2,018 total
Purchase
CHIMERIX INC
Common Stock
2020-03-12$1.45/sh+72,995→ 102,995 total
Award
CHIMERIX INC
Stock Option (Right to Buy)
2020-01-21+632,500→ 632,500 total
Purchase
CHIMERIX INC
Common Stock
2019-05-20$3.48/sh+30,000→ 30,000 total
Award
CHIMERIX INC
Employee Stock Option (Right to Buy)
2019-04-08+1,250,000→ 1,250,000 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−37,500→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$14.14/sh−58,719→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$12.89/sh−36,000→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$21.84/sh−187,500→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$20.99/sh−225,000→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−23,438→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−7,188→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$20.45/sh−74,998→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−19,919→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−243,739→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$20.82/sh−86,248→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−62,500→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$14.95/sh−20,800→ 0 total
Disposition to Issuer
ENDOCYTE INC
Common Stock
2018-12-21$24.00/sh−5,000→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$18.90/sh−86,247→ 0 total
Disposition to Issuer
ENDOCYTE INC
Stock Option (right to buy)
2018-12-21$20.32/sh−60,000→ 0 total
Exercise/Conversion
ENDOCYTE INC
Common Stock
2018-12-17$11.11/sh+9,000→ 463,472 total

Companies

Recent Filings

Address

C/O AKTIS ONCOLOGY, INC. 17 DRYDOCK AVENUE, SUITE 17-401

BOSTON, MA, 02210

View on SEC.gov